1. Home
  2. MCB vs MGTX Comparison

MCB vs MGTX Comparison

Compare MCB & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metropolitan Bank Holding Corp.

MCB

Metropolitan Bank Holding Corp.

N/A

Current Price

$93.29

Market Cap

1.1B

Sector

Finance

ML Signal

N/A

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$10.44

Market Cap

909.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCB
MGTX
Founded
1999
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
909.1M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
MCB
MGTX
Price
$93.29
$10.44
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$98.67
$24.57
AVG Volume (30 Days)
85.8K
723.3K
Earning Date
04-21-2026
05-12-2026
Dividend Yield
1.13%
N/A
EPS Growth
11.64
33.02
EPS
2.92
N/A
Revenue
$11,053,000.00
$81,391,000.00
Revenue This Year
$37.22
$141.38
Revenue Next Year
$14.75
N/A
P/E Ratio
$32.84
N/A
Revenue Growth
N/A
144.57
52 Week Low
$64.55
$6.30
52 Week High
$97.84
$11.85

Technical Indicators

Market Signals
Indicator
MCB
MGTX
Relative Strength Index (RSI) 53.70 61.38
Support Level $86.38 $8.84
Resistance Level $93.56 $10.46
Average True Range (ATR) 2.52 0.58
MACD 0.31 0.07
Stochastic Oscillator 55.12 80.74

Price Performance

Historical Comparison
MCB
MGTX

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: